Curaleaf Holdings (CURLF) Net Income (QoQ) (2019 - 2026)
Curaleaf Holdings (CURLF) Net Income (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -386,990.74% |
| Sep 30, 2025 | 99.93% |
| Jun 30, 2025 | -29,371.21% |
| Mar 31, 2025 | 9.86% |
| Dec 31, 2024 | -798.02% |
| Sep 30, 2024 | 226.86% |
| Jun 30, 2024 | -325.22% |
| Mar 31, 2024 | 100.01% |
| Dec 31, 2023 | -30,750.86% |
| Sep 30, 2023 | -227.87% |
| Jun 30, 2023 | 37.22% |
| Mar 31, 2023 | 85.42% |
| Dec 31, 2022 | -578.28% |
| Sep 30, 2022 | -182.77% |
| Jun 30, 2022 | -121.06% |
| Mar 31, 2022 | 507.80% |
| Dec 31, 2021 | -108.33% |
| Sep 30, 2021 | -18.20% |
| Jun 30, 2021 | 65.17% |